If you liked this article you might like

Which Stocks Hurt Billionaire Portfolios the Most in 2014?

Enzymotec: John Paulson Bought 20 Percent - Should You Follow Suit?

Medical IPOs: Foundation, Enzymotec and Premier

Medical IPOs: Foundation, Enzymotec and Premier